News - Eliquis, ALN-TMP


Current filters:


Popular Filters

1 to 25 of 40 results

Pfizer revenues down as patent losses hit sales

Pfizer revenues down as patent losses hit sales


Global pharma giant Pfizer has said worldwide sales fell 2% to $12.6 billion, hurt by generic competition,…

AriceptEliquisEnbrelFinancialLipitorNorth AmericaPfizerPharmaceuticalRebifSpiriva

Bayer/Janssen's Xarelto poised to lead sales in VTE market: report


German drug major Bayer (BAYN: DE) and Johnson & Johnson (NYSE: JNJ) subsidiary Janssen's Xarelto (rivaroxaban)…

BayerBristol-Myers SquibbCardio-vascularEliquisGlobalJanssenJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

US FDA accepts Bristol-Myers/Pfizer' Eliquis sNDA


US pharma major Bristol-Myers Squibb (NYSE: BMY) and behemoth Pfizer (NYSE: PFE) announced that the US…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Positive results from sub-analysis of Eliquis ARISTOTLE trial


US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) reported results from a…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalResearch

Germany's IQWiG finds considerable added benefit for Bristol-Myers/Pfizer's Eliquis


In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalPricingRegulation

Xarelto and Eliquis set to displace current therapies in DVT/PE


Clinical data and the opinions of interviewed thought leaders indicate that there is little to distinguish…

BayerBristol-Myers SquibbCardio-vascularEliquisEuropeJohnson & JohnsonMarkets & MarketingNorth AmericaPfizerPharmaceuticalXarelto

US FDA finally approves Bristol-Myers/Pfizer's Eliquis for stroke prevention in AF patients


The US Food and Drug Administration on December 28 finally approved the anti-clotting drug Eliquis (apixaban),…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Bristol-Myers and Pfizer's Eliquis sees first European launch, in the UK


US drug major Bristol-Myers Squibb (NYSE: BMY) and partner global pharma behemoth Pfizer (NYSE: PFE)…

Bristol-Myers SquibbCardio-vascularEliquisEuropeMarkets & MarketingPfizerPharmaceutical

Bristol-Myers/Pfizer's Eliquis gets EU backing for stroke prevention and NVAF


US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE), the world's largest drugmaker…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalRegulation

FDA sets March 2013 PDUFA date for re-submitted Eliquis


The US Food and Drug Administration has acknowledged receipt of the New Drug Application resubmission…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Decline in cardiovascular drugs noted at ESC congress


This year's European Society of Cardiology (ESC) Congress in Munich, Germany, was a stark example of…

apixabanBristol-Myers SquibbCardio-vascularEliquisMarkets & MarketingPfizerPharmaceuticalResearch

1 to 25 of 40 results

Company Spotlight



Back to top